Molecular markers of glioma: an update on recent progress and perspectives
作者： Kirti Gupta , Pravin Salunke
DOI: 10.1007/S00432-012-1323-Y
关键词:
摘要: Background Significant progress has been made in the molecular diagnostic subtyping of brain tumors especially gliomas. Designing effective tailored therapy remains cornerstone for delving into heterogeneity and classification More homogenous tumor populations may lead to more uniform responses particular constellation. Recent decade seen a surge markers glioma which hold promise potential being strong prognostic, predictive, markers. They are also extremely critical stratification current clinical trails.
springer.com
sci-hub.se 参考文章(84)
Craig Horbinski, C Ryan Miller, Arie Perry, Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade Brain Pathology. ,vol. 21, pp. 57- 73 ,(2011) , 10.1111/J.1750-3639.2010.00453.X
David Capper, Susanne WeiÃert, Jörg Balss, Antje Habel, Jochen Meyer, Diana Jäger, Ulrike Ackermann, Claudia Tessmer, Andrey Korshunov, Hanswalter Zentgraf, Christian Hartmann, Andreas Von Deimling, Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathology. ,vol. 20, pp. 245- 254 ,(2010) , 10.1111/J.1750-3639.2009.00352.X
K. Masui, T. F. Cloughesy, P. S. Mischel, Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies. Neuropathology and Applied Neurobiology. ,vol. 38, pp. 271- 291 ,(2012) , 10.1111/J.1365-2990.2011.01238.X
M. Huncharek, B. Kupelnick, Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. Oncology Research. ,vol. 12, pp. 107- 112 ,(2001) , 10.3727/096504001108747576
M. Hasselblatt, B. Riesmeier, B. Lechtape, A. Brentrup, W. Stummer, F. K. Albert, A. Sepehrnia, H. Ebel, J. Gerß, W. Paulus, BRAF‐KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults Neuropathology and Applied Neurobiology. ,vol. 37, pp. 803- 806 ,(2011) , 10.1111/J.1365-2990.2011.01193.X
Ronald L. Hamilton, Marina N. Nikiforova, Molecular diagnostics of gliomas. Archives of Pathology & Laboratory Medicine. ,vol. 135, pp. 558- 568 ,(2011) , 10.1043/2010-0649-RAIR.1
Naoki Shinojima, Kenji Tada, Shoji Shiraishi, Takanori Kamiryo, Masato Kochi, Hideo Nakamura, Keishi Makino, Hideyuki Saya, Hirofumi Hirano, Jun-ichi Kuratsu, Koji Oka, Yasuji Ishimaru, Yukitaka Ushio, None, Prognostic Value of Epidermal Growth Factor Receptor in Patients with Glioblastoma Multiforme Cancer Research. ,vol. 63, pp. 6962- 6970 ,(2003)
S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.-L. Guan, Y. Xiong, Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α Science. ,vol. 324, pp. 261- 265 ,(2009) , 10.1126/SCIENCE.1170944
Andrew M. Donson, Steven O. Addo-Yobo, Michael H. Handler, Lia Gore, Nicholas K. Foreman, MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma Pediatric Blood & Cancer. ,vol. 48, pp. 403- 407 ,(2007) , 10.1002/PBC.20803
Gordon Li, Albert J Wong, EGF receptor variant III as a target antigen for tumor immunotherapy Expert Review of Vaccines. ,vol. 7, pp. 977- 985 ,(2008) , 10.1586/14760584.7.7.977